Modulation of neural plasticity as a basis for stroke rehabilitation

Stroke

Volumn 43, Issue 10, 2012, Pages 2819-2828

  Pekna, Marcela ^a   Pekny, Milos ^a   Nilsson, Michael ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

adjuvant therapies; multisensory stimulation; neural plasticity; neurorehabilitation; stroke

Indexed keywords

4 AMINOBUTYRIC ACID; BENZODIAZEPINE RECEPTOR BLOCKING AGENT; BETA LACTAM ANTIBIOTIC; BRAIN DERIVED NEUROTROPHIC FACTOR; CUTAMESINE; DEXAMPHETAMINE; DOPAMINE; ERYTHROPOIETIN; FLUOXETINE; GLUTAMIC ACID; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; INOSINE; L 655 708; LEVODOPA; NICOTINIC ACID; NOGO A ANTIBODY; PROTEIN C FOS; REACTIVE OXYGEN METABOLITE; RECOMBINANT BASIC FIBROBLAST GROWTH FACTOR; SEROTONIN; SILDENAFIL; SOMATOMEDIN C; TADALAFIL; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG;

ASTROCYTE; BLOOD BRAIN BARRIER; BONE MARROW TRANSPLANTATION; BRAIN BLOOD FLOW; BRAIN INFARCTION SIZE; BRAIN INJURY; BRAIN MAPPING; CELL MIGRATION; CELL SURVIVAL; CELL THERAPY; CENTRAL NERVOUS SYSTEM; COGNITION; DAILY LIFE ACTIVITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FOLLOW UP; GENETIC MANIPULATION; HEMISPHERE; HIPPOCAMPUS; HORMONE RELEASE; HUMAN; HYPERPOLARIZATION; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOTHERAPY; IN VITRO STUDY; INNATE IMMUNITY; LONG TERM DEPRESSION; LONG TERM POTENTIATION; MENTAL PERFORMANCE; MESENCHYMAL STEM CELL; META ANALYSIS (TOPIC); MIRROR THERAPY; MOTOR PERFORMANCE; NERVE CELL MEMBRANE STEADY POTENTIAL; NERVE CELL PLASTICITY; NERVE FIBER; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; NEURAL STEM CELL TRANSPLANTATION; NEUROPROTECTION; NONHUMAN; OCCUPATIONAL THERAPY; OLFACTORY BULB; OLIGODENDROGLIA; ONCOGENE C FOS; PATIENT SAFETY; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PHYSIOTHERAPY; PREMOTOR CORTEX; PRIMARY MOTOR CORTEX; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; PYRAMIDAL TRACT; REHABILITATION; REVIEW; SENSORIMOTOR CORTEX; SENSORIMOTOR FUNCTION; SOMATOSENSORY CORTEX; SPINAL CORD INJURY; STIMULATION; STROKE; STROKE PATIENT; SYNAPSE; SYNAPTOGENESIS; THERAPY; TRAINING; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME;

BEHAVIOR CONTROL; CHEMOTHERAPY, ADJUVANT; HUMANS; NEURONAL PLASTICITY; RECOVERY OF FUNCTION; STROKE; TREATMENT OUTCOME;

EID: 84866731311     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.112.654228     Document Type: Review

References (135)

1. Wieloch T, Nikolich K. Mechanisms of neural plasticity following brain injury. Curr Opin Neurobiol. 2006;16:258-264. (Pubitemid 43949227)
2. Warraich Z, Kleim JA. Neural plasticity: the biological substrate for neurorehabilitation. PM R. 2010;2:S208-S219.
3. Merzenich MM, Kaas JH, Wall J, Nelson RJ, Sur M, Felleman D. Topographic reorganization of somatosensory cortical areas 3b and 1 in adult monkeys following restricted deafferentation. Neuroscience. 1983; 8:33-55. (Pubitemid 13175354)
4. Wrigley PJ, Press SR, Gustin SM, Macefield VG, Gandevia SC, Cousins MJ, et al. Neuropathic pain and primary somatosensory cortex reorganization following spinal cord injury. Pain. 2009;141:52-59.
5. Henderson LA, Gustin SM, Macey PM, Wrigley PJ, Siddall PJ. Functional reorganization of the brain in humans following spinal cord injury: evidence for underlying changes in cortical anatomy. J Neurosci. 2011;31:2630-2637.
6. Liu Y, Rouiller EM. Mechanisms of recovery of dexterity following unilateral lesion of the sensorimotor cortex in adult monkeys. Brain Res. 1999;128:149-159. (Pubitemid 29425614)
7. Gerloff C, Bushara K, Sailer A, Wassermann EM, Chen R, Matsuoka T, et al. Multimodal imaging of brain reorganization in motor areas of the contralesional hemisphere of well recovered patients after capsular stroke. Brain. 2006;129:791-808. (Pubitemid 43278240)
8. Feydy A, Carlier R, Roby-Brami A, Bussel B, Cazalis F, Pierot L, et al. Longitudinal study of motor recovery after stroke: recruitment and focusing of brain activation. Stroke. 2002;33:1610-1617. (Pubitemid 34619967)
9. Werhahn KJ, Conforto AB, Kadom N, Hallett M, Cohen LG. Contribution of the ipsilateral motor cortex to recovery after chronic stroke. Ann Neurol. 2003;54:464-472. (Pubitemid 37176541)
10. Fridman EA, Hanakawa T, Chung M, Hummel F, Leiguarda RC, Cohen LG. Reorganization of the human ipsilesional premotor cortex after stroke. Brain. 2004;127:747-758. (Pubitemid 38478519)
11. Bütefisch CM, Kleiser R, Seitz RJ. Post-lesional cerebral reorganisation: evidence from functional neuroimaging and transcranial magnetic stimulation. J Physiol. 2006;99:437-454. (Pubitemid 43850796)
12. Jankowska E, Edgley SA. How can corticospinal tract neurons contribute to ipsilateral movements? A question with implications for recovery of motor functions. Neuroscientist. 2006;12:67-79. (Pubitemid 43122384)
13. Chollet F, DiPiero V, Wise RJ, Brooks DJ, Dolan RJ, Frackowiak RS. The functional anatomy of motor recovery after stroke in humans: a study with positron emission tomography. Ann Neurol. 1991;29:63-71.
14. Zemke AC, Heagerty PJ, Lee C, Cramer SC. Motor cortex organization after stroke is related to side of stroke and level of recovery. Stroke. 2003;34:e23-e28.
15. Enzinger C, Johansen-Berg H, Dawes H, Bogdanovic M, Collett J, Guy C, et al. Functional MRI correlates of lower limb function in stroke victims with gait impairment. Stroke. 2008;39:1507-1513.
16. Xerri C. Plasticity of cortical maps: Multiple triggers for adaptive reorganization following brain damage and spinal cord injury. Neuroscientist. 2012;18:133-148.
17. Murphy TH, Corbett D. Plasticity during stroke recovery: from synapse to behaviour. Nat Rev Neurosci. 2009;10:861-872.
18. Marshall RS, Zarahn E, Alon L, Minzer B, Lazar RM, Krakauer JW. Early imaging correlates of subsequent motor recovery after stroke. Ann Neurol. 2009;65:596-602.
19. Liu Z, Zhang RL, Li Y, Cui Y, Chopp M. Remodeling of the corticospinal innervation and spontaneous behavioral recovery after ischemic stroke in adult mice. Stroke. 2009;40:2546-2551.
20. Alvarez-Buylla A, Lim DA. For the long run: maintaining germinal niches in the adult brain. Neuron. 2004;41:683-686. (Pubitemid 38326831)
21. Curtis MA, Kam M, Nannmark U, Anderson MF, Axell MZ, Wikkelso C, et al. Human neuroblasts migrate to the olfactory bulb via a lateral ventricular extension. Science. 2007;315:1243-1249. (Pubitemid 46364256)
22. Arvidsson A, Collin T, Kirik D, Kokaia Z, Lindvall O. Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat Med. 2002;8:963-970. (Pubitemid 35033700)
23. Jäderstad J, Jäderstad LM, Li J, Chintawar S, Salto C, Pandolfo M, et al. Communication via gap junctions underlies early functional and beneficial interactions between grafted neural stem cells and the host. Proc Natl Acad Sci U S A. 2010;107:5184-5189.
24. Hermann DM, Chopp M. Promoting brain remodelling and plasticity for stroke recovery: therapeutic promise and potential pitfalls of clinical translation. Lancet Neurol. 2012;11:369-380.
25. Nithianantharajah J, Hannan AJ. Enriched environments, experiencedependent plasticity and disorders of the nervous system. Nat Rev Neurosci. 2006;7:697-709. (Pubitemid 44267494)
26. Janssen H, Bernhardt J, Collier JM, Sena ES, McElduff P, Attia J, et al. An enriched environment improves sensorimotor function post-ischemic stroke. Neurorehabil Neural Repair. 2010;24:802-813.
27. Johansson BB. Current trends in stroke rehabilitation. A review with focus on brain plasticity. Acta Neurol Scand. 2011;123:147-159.
28. Ghazanfar AA, Schroeder CE. Is neocortex essentially multisensory? Trends Cogn Sci. 2006;10:278-285. (Pubitemid 43870163)
29. Shams L, Seitz AR. Benefits of multisensory learning. Trends Cogn Sci. 2008;12:411-407.
30. Yavuzer G, Selles R, Sezer N, Sütbeyaz S, Bussmann JB, Köseoglu F, et al. Mirror therapy improves hand function in subacute stroke: a randomized controlled trial. Arch Phys Med Rehabil. 2008;89:393-398. (Pubitemid 351273169)
31. Dohle C, Püllen J, Nakaten A, Küst J, Rietz C, Karbe H. Mirror therapy promotes recovery from severe hemiparesis: a randomized controlled trial. Neurorehabil Neural Repair. 2009;23:209-217.
32. Rothgangel AS, Braun SM, Beurskens AJ, Seitz RJ, Wade DT. The clinical aspects of mirror therapy in rehabilitation: a systematic review of the literature. Int J Rehabil Res. 2011;34:1-13.
33. Ertelt D, Small S, Solodkin A, Dettmers C, McNamara A, Binkofski F, et al. Action observation has a positive impact on rehabilitation of motor deficits after stroke. Neuroimage. 2007;36:T164-T173. (Pubitemid 46702737)
34. Celnik P, Webster B, Glasser DM, Cohen LG. Effects of action observation on physical training after stroke. Stroke. 2008;39:1814-1820.
35. Page SJ, Levine P, Leonard A. Mental practice in chronic stroke: results of a randomized, placebo-controlled trial. Stroke. 2007;38:1293-1297. (Pubitemid 351664256)
36. Lotze M, Halsband U. Motor imagery. J Physiol. 2006;99:135-140.
37. Carter AR, Connor LT, Dromerick AW. Rehabilitation after stroke: current state of the science. Curr Neurol Neurosci Rep. 2010;10: 158-166.
38. Saposnik G, Teasell R, Mamdani M, Hall J, McIlroy W, Cheung D, et al. Effectiveness of virtual reality using Wii gaming technology in stroke rehabilitation: a pilot randomized clinical trial and proof of principle. Stroke. 2010;41:1477-1484.
39. da Silva Cameirão M, Bermúdez, Badia S, Duarte E, Verschure PF. Virtual reality based rehabilitation speeds up functional recovery of the upper extremities after stroke: A randomized controlled pilot study in the acute phase of stroke using the Rehabilitation Gaming System. Restor Neurol Neurosci. 2011;29:287-298.
40. Chen JL, Penhune VB, Zatorre RJ. Listening to musical rhythms recruits motor regions of the brain. Cereb Cortex. 2008;18:2844-2854.
41. Kim J, Wigram T, Gold C. The effects of improvisational music therapy on joint attention behaviors in autistic children: a randomized controlled study. J Autism Dev Disord. 2008;38:1758-1766.
42. Zatorre R, McGill J. Music, the food of neuroscience? Nature. 2005; 434:312-315. (Pubitemid 40469166)
43. Särkämö T, Tervaniemi M, Laitinen S, Forsblom A, Soinila S, Mikkonen M, et al. Music listening enhances cognitive recovery and mood after middle cerebral artery stroke. Brain. 2008;131:866-876. (Pubitemid 351294728)
44. Särkämö T, Pihko E, Laitinen S, Forsblom A, Soinila S, Mikkonen M, et al. Music and speech listening enhance the recovery of early sensory processing after stroke. J Cogn Neurosci. 2009;22:2716-2727.
45. Soto D, Funes MJ, Guzmán-García A, Warbrick T, Rotshtein P, Humphreys GW. Pleasant music overcomes the loss of awareness in patients with visual neglect. Proc Natl Acad Sci U S A. 2009;106:6011-6016.
46. Bolognini N, Pascual-Leone A, Fregni F. Using non-invasive brain stimulation to augment motor training-induced plasticity. J Neuroeng Rehabil. 2009;6:8.
47. Dimyan MA, Cohen LG. Neuroplasticity in the context of motor rehabilitation after stroke. Nat Rev Neurol. 2011;7:76-85.
48. Lindenberg R, Renga V, Zhu LL, Nair D, Schlaug G. Bihemispheric brain stimulation facilitates motor recovery in chronic stroke patients. Neurology. 2010;75:2176-2184.
49. Goldstein LB. Amphetamine trials and tribulations. Stroke. 2009;40: S133-S135.
50. Cheatwood JL, Emerick AJ, Kartje GL. Neuronal plasticity and functional recovery after ischemic stroke. Top Stroke Rehabil. 2008;15: 42-50. (Pubitemid 351160091)
51. Martinsson L, Hardemark HG, Eksborg S. Should amphetamines be given to improve recovery after stroke? Stroke. 2007;38:2400-2401. (Pubitemid 47457595)
52. Schuster C, Maunz G, Lutz K, Kischka U, Sturzenegger R, Ettlin T. Dexamphetamine improves upper extremity outcome during rehabilitation after stroke: a pilot randomized controlled trial. Neurorehabil Neural Repair. 2011;25:749-755.
53. Scheidtmann K, Fries W, Müller F, Koenig E. Effect of levodopa in combination with physiotherapy on functional motor recovery after stroke: a prospective, randomised, double-blind study. Lancet. 2001; 358:787-790. (Pubitemid 32868727)
54. Stroemer RP, Kent TA, Hulsebosch CE. Enhanced neocortical neural sprouting, synaptogenesis, and behavioral recovery with D-amphetamine therapy after neocortical infarction in rats. Stroke. 1998; 29:2381-2393; discussion 2393-2395.
55. Ruscher K, Kuric E, Wieloch T. Levodopa treatment improves functional recovery after experimental stroke. Stroke. 2012;43:507-513.
56. Ruscher K, Shamloo M, Rickhag M, Ladunga I, Soriano L, Gisselsson L, et al. The sigma-1 receptor enhances brain plasticity and functional recovery after experimental stroke. Brain. 2011;134:732-746.
57. Pinnock SB, Blake AM, Platt NJ, Herbert J. The roles of BDNF, pCREB and Wnt3a in the latent period preceding activation of progenitor cell mitosis in the adult dentate gyrus by fluoxetine. PLoS ONE. 2010;5: e13652.
58. Homberg JR, Olivier JD, Blom T, Arentsen T, van Brunschot C, Schipper P, et al. Fluoxetine exerts age-dependent effects on behavior and amygdala neuroplasticity in the rat. PLoS ONE. 2011;6:e16646.
59. Chollet F, Tardy J, Albucher JF, Thalamas C, Berard E, Lamy C, et al. Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial. Lancet Neurol. 2011;10:123-130.
60. Vosper H. Niacin: a re-emerging pharmaceutical for the treatment of dyslipidaemia. Br J Pharmacol. 2009;158:429-441.
61. Chen J, Cui X, Zacharek A, Jiang H, Roberts C, Zhang C, et al. Niaspan increases angiogenesis and improves functional recovery after stroke. Ann Neurol. 2007;62:49-58. (Pubitemid 47235280)
62. Chen J, Cui X, Zacharek A, Ding GL, Shehadah A, Jiang Q, et al. Niaspan treatment increases tumor necrosis factor-alpha-converting enzyme and promotes arteriogenesis after stroke. J Cereb Blood Flow Metab. 2009;29:911-920.
63. Cui X, Chopp M, Zacharek A, Roberts C, Buller B, Ion M, et al. Niacin treatment of stroke increases synaptic plasticity and axon growth in rats. Stroke. 2010;41:2044-2049.
64. Chen P, Goldberg DE, Kolb B, Lanser M, Benowitz LI. Inosine induces axonal rewiring and improves behavioral outcome after stroke. Proc Natl Acad Sci U S A. 2002;99:9031-9036. (Pubitemid 34693678)
65. Zai L, Ferrari C, Subbaiah S, Havton LA, Coppola G, Strittmatter S, et al. Inosine alters gene expression and axonal projections in neurons contralateral to a cortical infarct and improves skilled use of the impaired limb. J Neurosci. 2009;29:8187-8197.
66. Zai L, Ferrari C, Dice C, Subbaiah S, Havton LA, Coppola G, et al. Inosine augments the effects of a Nogo receptor blocker and of environmental enrichment to restore skilled forelimb use after stroke. J Neurosci. 2011;31:5977-5988.
67. Gonsette RE, Sindic C, D'hooghe MB, De Deyn PP, Medaer R, Michotte A, et al. Boosting endogenous neuroprotection in multiple sclerosis: the ASsociation of Inosine and Interferon beta in relapsingremitting Multiple Sclerosis (ASIIMS) trial. Mult Scler. 2010;16: 455-462.
68. Papadopoulos CM, Tsai SY, Alsbiei T, O'Brien TE, Schwab ME, Kartje GL. Functional recovery and neuroanatomical plasticity following middle cerebral artery occlusion and IN-1 antibody treatment in the adult rat. Ann Neurol. 2002;51:433-441. (Pubitemid 34260773)
69. Wiessner C, Bareyre FM, Allegrini PR, Mir AK, Frentzel S, Zurini M, et al. Anti-Nogo-A antibody infusion 24 hours after experimental stroke improved behavioral outcome and corticospinal plasticity in normotensive and spontaneously hypertensive rats. J Cereb Blood Flow Metab. 2003;23:154-165. (Pubitemid 36188454)
70. Tsai SY, Markus TM, Andrews EM, Cheatwood JL, Emerick AJ, Mir AK, et al. Intrathecal treatment with anti-Nogo-A antibody improves functional recovery in adult rats after stroke. Exp Brain Res. 2007;182: 261-266. (Pubitemid 350218894)
71. Papadopoulos CM, Tsai SY, Cheatwood JL, Bollnow MR, Kolb BE, Schwab ME, et al. Dendritic plasticity in the adult rat following middle cerebral artery occlusion and Nogo-a neutralization. Cereb Cortex. 2006;16:529-536.
72. Lee JK, Kim JE, Sivula M, Strittmatter SM. Nogo receptor antagonism promotes stroke recovery by enhancing axonal plasticity. J Neurosci. 2004;24:6209-6217. (Pubitemid 38891112)
73. Tsai SY, Papadopoulos CM, Schwab ME, Kartje GL. Delayed antinogo-a therapy improves function after chronic stroke in adult rats. Stroke. 2011;42:186-190.
74. Gou X, Wang Q, Yang Q, Xu L, Xiong L. TAT-NEP1-40 as a novel therapeutic candidate for axonal regeneration and functional recovery after stroke. J Drug Target. 2011;19:86-95.
75. Zörner B, Schwab ME. Anti-Nogo on the go: from animal models to a clinical trial. Ann N Y Acad Sci. 2010;1198:E22-E34.
76. Cramer SC. Repairing the human brain after stroke: I. Mechanisms of spontaneous recovery. Ann Neurol. 2008;63:272-287. (Pubitemid 351499857)
77. Brown CE, Aminoltejari K, Erb H, Winship IR, Murphy TH. In vivo voltage-sensitive dye imaging in adult mice reveals that somatosensory maps lost to stroke are replaced over weeks by new structural and functional circuits with prolonged modes of activation within both the peri-infarct zone and distant sites. J Neurosci. 2009;29:1719-1734.
78. Clarkson AN, Huang BS, Macisaac SE, Mody I, Carmichael ST. Reducing excessive GABA-mediated tonic inhibition promotes functional recovery after stroke. Nature. 2010;468:305-309.
79. Atack JR, Bayley PJ, Seabrook GR, Wafford KA, McKernan RM, Dawson GR. L-655,708 enhances cognition in rats but is not proconvulsant at a dose selective for alpha5-containing GABAA receptors. Neuropharmacology. 2006;51:1023-1029. (Pubitemid 44691810)
80. Farooq MU, Naravetla B, Moore PW, Majid A, Gupta R, Kassab MY. Role of sildenafil in neurological disorders. Clin Neuropharmacol. 2008;31:353-362.
81. Zhang R, Wang Y, Zhang L, Zhang Z, Tsang W, Lu M, et al. Sildenafil (Viagra) induces neurogenesis and promotes functional recovery after stroke in rats. Stroke. 2002;33:2675-2680. (Pubitemid 35266440)
82. Zhang L, Zhang RL, Wang Y, Zhang C, Zhang ZG, Meng H, et al. Functional recovery in aged and young rats after embolic stroke: treatment with a phosphodiesterase type 5 inhibitor. Stroke. 2005;36: 847-852.
83. Zhang L, Zhang Z, Zhang RL, Cui Y, LaPointe MC, Silver B, et al. Tadalafil, a long-acting type 5 phosphodiesterase isoenzyme inhibitor, improves neurological functional recovery in a rat model of embolic stroke. Brain Res. 2006;1118:192-198. (Pubitemid 44633866)
84. Silver B, Grover KM, Arcila X, Mitsias PD, Bowyer SM, Chopp M. Recovery in a patient with locked-in syndrome. Can J Neurol Sci. 2006;33:246-249. (Pubitemid 43845185)
85. Cocchiarella A. Partial motor restoration upon administration of sildenafil: a case study. Dev Neurorehabil. 2012;15:39-43.
86. Silver B, McCarthy S, Lu M, Mitsias P, Russman AN, Katramados A, et al. Sildenafil treatment of subacute ischemic stroke: a safety study at 25-mg daily for 2 weeks. J Stroke Cerebrovasc Dis. 2009;18:381-383.
87. Sun Y, Jin K, Xie L, Childs J, Mao XO, Logvinova A, et al. VEGFinduced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J Clin Invest. 2003;111:1843-1851. (Pubitemid 38057729)
88. Zhang ZG, Zhang L, Jiang Q, Zhang R, Davies K, Powers C, et al. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J Clin Invest. 2000;106:829-838.
89. Jerndal M, Forsberg K, Sena ES, Macleod MR, O'Collins VE, Linden T, et al. A systematic review and meta-analysis of erythropoietin in experimental stroke. J Cereb Blood Flow Metab. 2010;30:961-968.
90. Jia L, Chopp M, Zhang L, Lu M, Zhang Z. Erythropoietin in combination of tissue plasminogen activator exacerbates brain hemorrhage when treatment is initiated 6 hours after stroke. Stroke. 2010;41: 2071-2076.
91. Zechariah A, ElAli A, Hermann DM. Combination of tissue-plasminogen activator with erythropoietin induces blood-brain barrier permeability, extracellular matrix disaggregation, and DNA fragmentation after focal cerebral ischemia in mice. Stroke. 2010;41:1008-1012.
92. Ehrenreich H, Weissenborn K, Prange H, Schneider D, Weimar C, Wartenberg K, et al. Recombinant human erythropoietin in the treatment of acute ischemic stroke. Stroke. 2009;40:e647-656.
93. Reitmeir R, Kilic E, Kilic U, Bacigaluppi M, ElAli A, Salani G, et al. Post-acute delivery of erythropoietin induces stroke recovery by promoting perilesional tissue remodelling and contralesional pyramidal tract plasticity. Brain. 2011;134:84-99.
94. Minnerup J, Sevimli S, Schäbitz WR. Granulocyte-colony stimulating factor for stroke treatment: mechanisms of action and efficacy in preclinical studies. Exp Transl Stroke Med. 2009;1:2.
95. Boy S, Sauerbruch S, Kraemer M, Schormann T, Schlachetzki F, Schuierer G, et al. Mobilisation of hematopoietic CD34-precursor cells in patients with acute stroke is safe-results of an open-labeled non randomized phase I/II trial. PLoS ONE. 2011;6:e23099.
96. England TJ, Abaei M, Auer DP, Lowe J, Jones DR, Sare G, et al. Granulocyte-colony stimulating factor for mobilizing bone marrow stem cells in subacute stroke: the stem cell trial of recovery enhancement after stroke 2 randomized controlled trial. Stroke. 2012; 43:405-411.
97. Floel A, Warnecke T, Duning T, Lating Y, Uhlenbrock J, Schneider A, et al. Granulocyte-colony stimulating factor (G-CSF) in stroke patients with concomitant vascular disease-a randomized controlled trial. PLoS ONE. 2011;6:e19767.
98. Schäbitz WR, Steigleder T, Cooper-Kuhn CM, Schwab S, Sommer C, Schneider A, et al. Intravenous brain-derived neurotrophic factor enhances poststroke sensorimotor recovery and stimulates neurogenesis. Stroke. 2007;38:2165-2172. (Pubitemid 47012284)
99. Müller HD, Hanumanthiah KM, Diederich K, Schwab S, Schäbitz WR, Sommer C. Brain-derived neurotrophic factor but not forced arm use improves long-term outcome after photothrombotic stroke and transiently upregulates binding densities of excitatory glutamate receptors in the rat brain. Stroke. 2008;39:1012-1021. (Pubitemid 351619554)
100. Aberg D, Jood K, Blomstrand C, Jern C, Nilsson M, Isgaard J, et al. Serum IGF-I levels correlate to improvement of functional outcome after ischemic stroke. J Clin Endocrinol Metab. 2011:E1055-E1064.
101. De Smedt A, Brouns R, Uyttenboogaart M, De Raedt S, Moens M, Wilczak N, et al. Insulin-like growth factor I serum levels influence ischemic stroke outcome. Stroke. 2011;42:2180-2185.
102. Liu XF, Fawcett JR, Thorne RG, Frey WH II. Non-invasive intranasal insulin-like growth factor-I reduces infarct volume and improves neurologic function in rats following middle cerebral artery occlusion. Neurosci Lett. 2001;308:91-94. (Pubitemid 32703675)
103. Zhu W, Fan Y, Frenzel T, Gasmi M, Bartus RT, Young WL, et al. Insulin growth factor-1 gene transfer enhances neurovascular remodeling and improves long-term stroke outcome in mice. Stroke. 2008;39:1254-1261. (Pubitemid 351440699)
104. Paciaroni M, Bogousslavsky J. Trafermin for stroke recovery: is it time for another randomized clinical trial? Expert Opin Biol Ther. 2011;11: 1533-1541.
105. Shen LH, Li Y, Chen J, Cui Y, Zhang C, Kapke A, et al. One-year follow-up after bone marrow stromal cell treatment in middle-aged female rats with stroke. Stroke. 2007;38:2150-2156. (Pubitemid 47012282)
106. Liu Z, Li Y, Zhang X, Savant-Bhonsale S, Chopp M. Contralesional axonal remodeling of the corticospinal system in adult rats after stroke and bone marrow stromal cell treatment. Stroke. 2008;39:2571-2577.
107. Liu Z, Li Y, Zhang RL, Cui Y, Chopp M. Bone marrow stromal cells promote skilled motor recovery and enhance contralesional axonal connections after ischemic stroke in adult mice. Stroke. 2011;42:740-744.
108. Kokaia Z, Martino G, Schwartz M, Lindvall O. Cross-talk between neural stem cells and immune cells: the key to better brain repair? Nat Neurosci. 2012;5:1078-1087.
109. Chen J, Ye X, Yan T, Zhang C, Yang XP, Cui X, et al. Adverse effects of bone marrow stromal cell treatment of stroke in diabetic rats. Stroke. 2011;42:3551-3558.
110. Honmou O, Houkin K, Matsunaga T, Niitsu Y, Ishiai S, Onodera R, et al. Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke. Brain. 2011;134:1790-1807.
111. Zhang L, Li Y, Zhang C, Chopp M, Gosiewska A, Hong K. Delayed administration of human umbilical tissue-derived cells improved neurological functional recovery in a rodent model of focal ischemia. Stroke. 2011;42:1437-1444.
112. Lin YC, Ko TL, Shih YH, Lin MY, Fu TW, Hsiao HS, et al. Human umbilical mesenchymal stem cells promote recovery after ischemic stroke. Stroke. 2011;42:2045-2053.
113. Stroemer P, Patel S, Hope A, Oliveira C, Pollock K, Sinden J. The neural stem cell line CTX0E03 promotes behavioral recovery and endogenous neurogenesis after experimental stroke in a dose-dependent fashion. Neurorehabil Neural Repair. 2009;23:895-909.
114. Smith EJ, Stroemer RP, Gorenkova N, Nakajima M, Crum WR, Tang E, et al. Implantation site and lesion topology determine efficacy of a human neural stem cell line in a rat model of chronic stroke. Stem Cells. 2012;30:785-796.
115. Mulligan SJ, MacVicar BA. Calcium transients in astrocyte endfeet cause cerebrovascular constrictions. Nature. 2004;431:195-199. (Pubitemid 39243473)
116. Parpura V, Heneka MT, Montana V, Oliet SH, Schousboe A, Haydon PG, Stout RF Jr., Spray DC, Reichenbach A, Pannicke T, Pekny M, Pekna M, Zorec R, Verkhratsky A. Glial cells in (patho)physiology. J Neurochem. 2012;121:4-27.
117. Beck H, Plate KH. Angiogenesis after cerebral ischemia. Acta Neuropathol. 2009;117:481-496.
118. Sims NR, Nilsson M, Muyderman H. Mitochondrial glutathione: a modulator of brain cell death. J Bioenerg Biomembr. 2004;36:329-333. (Pubitemid 39619836)
119. Hertz L. Bioenergetics of cerebral ischemia: a cellular perspective. Neuropharmacology. 2008;55:289-309.
120. Rothstein JD, Patel S, Regan MR, Haenggeli C, Huang YH, Bergles DE, et al. Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature. 2005;433:73-77. (Pubitemid 40101145)
121. Pekny M, Pekna M. Astrocyte intermediate filaments in CNS pathologies and regeneration. J Pathol. 2004;204:428-437. (Pubitemid 39468154)
122. Pekny M, Nilsson M. Astrocyte activation and reactive gliosis. Glia. 2005;50:427-434. (Pubitemid 40780846)
123. Sofroniew MV. Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci. 2009;32:638-647.
124. Sofroniew MV, Vinters HV. Astrocytes: biology and pathology. Acta Neuropathol. 2010;119:7-35.
125. Li L, Lundkvist A, Andersson D, Wilhelmsson U, Nagai N, Pardo AC, et al. Protective role of reactive astrocytes in brain ischemia. J Cereb Blood Flow Metab. 2008;28:468-481. (Pubitemid 351304260)
126. Ullian EM, Sapperstein SK, Christopherson KS, Barres BA. Control of synapse number by glia. Science. 2001;291:657-661. (Pubitemid 32150425)
127. Wilhelmsson U, Li L, Pekna M, Berthold CH, Blom S, Eliasson C, et al. Absence of glial fibrillary acidic protein and vimentin prevents hyper-trophy of astrocytic processes and improves post-traumatic regeneration. J Neurosci. 2004;24:5016-5021. (Pubitemid 38697835)
128. Kinouchi R, Takeda M, Yang L, Wilhelmsson U, Lundkvist A, Pekny M, et al. Robust neural integration from retinal transplants in mice deficient in GFAP and vimentin. Nat Neurosci. 2003;6:863-868. (Pubitemid 36929708)
129. Widestrand A, Faijerson J, Wilhelmsson U, Smith PL, Li L, Sihlbom C, et al. Increased neurogenesis and astrogenesis from neural progenitor cells grafted in the hippocampus of GFAP-/-Vim-/-mice. Stem Cells. 2007;25:2619-2627. (Pubitemid 47582755)
130. Cho KS, Yang L, Ma HF, Lu B, Feng Ma H, Huaang X, et al. Re-establishing the regenerative potential of central nervous system axons in postnatal mice. J Cell Sci. 2005;118:863-872. (Pubitemid 40484879)
131. Pekny M, Wilhelmsson U, Rahpeymai Bogestal Y, Pekna M. The role of astrocytes and complement system in neural plasticity. Int Rev Neurobiol. 2007;82:95-111.
132. Wilhelmsson U, Faiz M, de Pablo Y, Sjoqvist M, Andersson D, Widestrand A, Potokar M, Stenovec M, Smith PL, Shinjyo N, Pekny T, Zorec R, Stahlberg A, Pekna M, Sahlgren C, and Pekny M. Astrocytes Negatively Regulate Neurogenesis through the Jagged1-mediated Notch Pathway. Stem Cells. 2012; in press.
133. Christopherson KS, Ullian EM, Stokes CC, Mullowney CE, Hell JW, Agah A, et al. Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis. Cell. 2005;120:421-433. (Pubitemid 40222435)
134. Liauw J, Hoang S, Choi M, Eroglu C, Choi M, Sun GH, et al. Thrombospondins 1 and 2 are necessary for synaptic plasticity and functional recovery after stroke. J Cereb Blood Flow Metab. 2008; 28:1722-1732.
135. Stevens B, Allen NJ, Vazquez LE, Howell GR, Christopherson KS, Nouri N, et al. The classical complement cascade mediates CNS synapse elimination. Cell. 2007;131:1164-1178. (Pubitemid 350235022)